Pharmaceutical policy in countries with developing healthcare systems / Zaheer-Ud-Din Babar, editor.
Babar, Zaheer-ud-din, editor.
2017
RA401.A1
Available Online

Linked e-resources

Linked Resource Online Access
Concurrent users Unlimited
Authorized users Authorized users
Document Delivery Supplied Can lend chapters, not whole ebooks

Details

Title Pharmaceutical policy in countries with developing healthcare systems / Zaheer-Ud-Din Babar, editor.
ISBN 9783319516738 (electronic book)
3319516736 (electronic book)
9783319516721
3319516728
DOI https://doi.org/10.1007/978-3-319-51673-8
Published Cham, Switzerland : Adis, 2017.
Language English
Description 1 online resource (xii, 430 pages) : illustrations.
Other Standard Identifiers 10.1007/978-3-319-51673-8 doi
Call Number RA401.A1
Dewey Decimal Classification 362.17/82
Summary A comprehensive and granular insight into the challenges of promoting rational medicine, this book serves as an essential resource for health policy makers and researchers interested in national medicines policies. Country-specific chapters have a common format, beginning with an overview of the health system and regulatory and policy environments, before discussing the difficulties in maintaining a medicines supply system, challenges in ensuring access to affordable medicines and issues impacting on rational medicine use. Numerous case studies are also used to highlight key issues and each chapter concludes with country-specific solutions to the issues raised. Written by highly regarded academics, the book includes countries in Africa, Asia, Europe, the Middle East and South America.
Access Note Access limited to authorized users.
Digital File Characteristics text file PDF
Source of Description Online resource; title from PDF title page (SpringerLink, viewed April 12, 2017).
Added Author Babar, Zaheer-ud-din, editor.
Available in Other Form Pharmaceutical policy in countries with developing healthcare systems.
Linked Resources Online Access
Record Appears in Online Resources > Ebooks
All Resources
Foreword; Preface; Contents; Chapter 1: Introduction; 1.1 Pharmaceutical Policy andßtheßRight toßHealth; 1.2 Pharmaceutical Production andßSupply; 1.3 Access toßAffordable Drugs; 1.4 Conclusion; References; Part I: Low and Lower Middle Income Countries; Chapter 2: Pharmaceutical Policy inßtheßEast African Community: Burundi, Kenya, Uganda, Rwanda, Tanzania; 2.1 Background; 2.1.1 Focus ofßThis Chapter; 2.1.2 Health System ofßtheßEAC (Health System andßHealth Indicators); 2.2 Pharmaceutical Situation ofßtheßEAC; 2.3 EAC Medicines Policy, Legislative andßRegulatory Environment.

2.4 Conclusions: Summary andßWay ForwardReferences; Chapter 3: Pharmaceutical Policy inßPakistan; 3.1 Pakistan; 3.1.1 Country Profile; 3.2 Health System ofßPakistan; 3.2.1 Health System; 3.2.2 Health Indicators; 3.3 Pharmaceutical Situation ofßtheßCountry; 3.3.1 Pharmaceutical Industry andßKey Statistics; 3.4 Country's Regulatory Environment; 3.4.1 Medicines Regulatory Authority; 3.4.2 Quality Control; 3.4.3 Pharmacovigilance; 3.4.4 Counterfeit Medicines; 3.5 Medicines Supply System; 3.5.1 Procurement; 3.5.2 Distribution; 3.6 Medicines Financing; 3.6.1 Medicines Expenditures inßGeneral.

3.6.2 Medicines Pricing3.6.3 Affordability; 3.6.4 Generic Medicines; 3.7 Medicines Use (Issues Impacting onßRationale Medicines Use inßtheßCountry); 3.7.1 Medicines Use inßGeneral (in Community Pharmacies, Dispensing Doctors andßGeneral Hospital Sector); 3.7.2 Essential Medicine List, Selection ofßEssential Medicines andßStandard Treatment Guidelines; 3.7.3 Prescribing Behaviour inßGeneral (Factors Affecting Prescribing Behaviour); 3.7.4 Medicines' Promotional Practices; 3.7.5 The Role ofßPharmacist inßCommunity andßHospital Environments.

3.7.6 Medicines Use Research (Including Drug Utilization Evaluation Research)3.8 Summary andßFuture Direction; References; Chapter 4: Pharmaceutical Policy inßtheßPhilippines; 4.1 The Philippines Health System; 4.1.1 Health System ofßPhilippines; 4.1.2 Health Indicators; 4.2 The Philippines Pharmaceutical Sector; 4.3 Pharmaceutical Regulation inßtheßPhilippines; 4.3.1 Quality Control; 4.3.2 Pharmacovigilance; 4.3.3 Substandard andßCounterfeit Medicines; 4.4 Medicines Supply System inßtheßPhilippines; 4.4.1 The Medicines Supply System; 4.5 Medicines Financing; 4.5.1 Medicine Pricing.

4.5.2 Price Monitoring4.5.3 Medicines Access; 4.5.4 Medicines Access Programs ofßtheßDOH; 4.5.5 Industry Patient Assistance Programmes; 4.5.6 Generic Medicines; 4.6 Medicines Use; 4.6.1 Medicines Use inßGeneral; 4.6.2 Essential Medicines andßStandard Treatment Guidelines; 4.6.3 Pharmacoeconomics; 4.6.4 Prescribing Behaviour; 4.6.5 Medicines Promotional Practices; 4.6.6 Role ofßPharmacist; 4.6.7 Pharmaceutical Care Interventions andßAssessment ofßCommunity Pharmacy Practice; 4.6.8 Medicines Use Research; 4.7 Conclusions andßWay Forward; References; Chapter 5: Pharmaceutical Policy inßVietnam.

Browse Subjects

Show more subjects...

Statistics

from
to
Export